Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multi-center, Randomized, Active-controlled, Single-blind, Parallel Two-group Trial of HQ® Matrix Soft Tissue Mesh and ULTRAPRO® Partially Absorbable Lightweight Mesh for the Treatment of Inguinal Hernia

NCT02487628 is registered in ClinicalTrials.gov with Zhejiang Xingyue Biotechnology Co., Ltd. as lead sponsor.

NCT NCT02487628
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02487628 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multi-center, Randomized, Active-controlled, Single-blind, Parallel Two-group Trial of HQ® Matrix Soft Tissue Mesh and ULTRAPRO® Partially Absorbable Lightweight Mesh for the Treatment of Inguinal Hernia
Lead sponsor
Zhejiang Xingyue Biotechnology Co., Ltd.
Phase
Not applicable
Overall status
Unknown status
Start date
November 30, 2014
Completion date
December 31, 2016
Enrollment
144 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

inguinal hernia